• STJ71474 Flow cytometric analysis of paraformaldehyde fixed K562 cells (blue line) , permeabilized with 0. 5% Triton. Primary incubation 1hr (10ug/ml) followed by Alexa Fluor 488 secondary antibody (1ug/ml). IgG control: Unimmunized goat IgG (black line) followed by Alexa Fluor 488 secondary antibody.

Anti-IFNAR2 antibody (Internal) (STJ71474)

SKU:
STJ71474-100

€379.38
Shipping:
Free Shipping
Current Stock:
Host: Goat
Applications: Pep-ELISA/FC/IHC
Reactivity: Human
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Goat polyclonal antibody anti-IFNAR2 (Internal) is suitable for use in ELISA, Flow Cytometry and Immunohistochemistry research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. NA
Purification: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Concentration: 0.5 mg/mL
Dilution Range: IHC-5µg/ml
FC-Flow cytometric analysis of K562 cells. 10ug/ml
ELISA-antibody detection limit dilution 1:32000.
Storage Instruction: Store at-20°C on receipt and minimise freeze-thaw cycles.
Gene Symbol: IFNAR2
Gene ID: 3455
Uniprot ID: INAR2_HUMAN
Immunogen Region: Internal
Accession Number: NP_000865.2 ; NP_997467.1; NP_997468.1
Specificity: This antibody is expected to recognise all three reported isoforms (NP_000865.2 ; NP_997467.1; NP_997468.1 )
Immunogen Sequence: SYDSPDYTDESCT
Post Translational Modifications Phosphorylated on tyrosine residues upon interferon binding. Phosphorylation at Tyr-337 or Tyr-512 are sufficient to mediate interferon dependent activation of STAT1, STAT2 and STAT3 leading to antiproliferative effects on many different cell types. Glycosylated.
Function Together with IFNAR1, forms the heterodimeric receptor for type I interferons (including interferons alpha, beta, epsilon, omega and kappa). Type I interferon binding activates the JAK-STAT signaling cascade, resulting in transcriptional activation or repression of interferon-regulated genes that encode the effectors of the interferon response. Mechanistically, type I interferon-binding brings the IFNAR1 and IFNAR2 subunits into close proximity with one another, driving their associated Janus kinases (JAKs) (TYK2 bound to IFNAR1 and JAK1 bound to IFNAR2) to cross-phosphorylate one another. The activated kinases phosphorylate specific tyrosine residues on the intracellular domains of IFNAR1 and IFNAR2, forming docking sites for the STAT transcription factors (STAT1, STAT2 and STAT). STAT proteins are then phosphorylated by the JAKs, promoting their translocation into the nucleus to regulate expression of interferon-regulated genes. Isoform 3: Potent inhibitor of type I IFN receptor activity.
Protein Name Interferon Alpha/Beta Receptor 2
Ifn-R-2
Ifn-Alpha Binding Protein
Ifn-Alpha/Beta Receptor 2
Interferon Alpha Binding Protein
Type I Interferon Receptor 2
Database Links Reactome: R-HSA-909733 P48551-2
Reactome: R-HSA-912694 P48551-2
Reactome: R-HSA-9679191 P48551-2
Reactome: R-HSA-9705671 P48551-2
Cellular Localisation Isoform 1: Cell Membrane
Single-Pass Type I Membrane Protein
Isoform 2: Cell Membrane
Isoform 3: Secreted
Alternative Antibody Names Anti-Interferon Alpha/Beta Receptor 2 antibody
Anti-Ifn-R-2 antibody
Anti-Ifn-Alpha Binding Protein antibody
Anti-Ifn-Alpha/Beta Receptor 2 antibody
Anti-Interferon Alpha Binding Protein antibody
Anti-Type I Interferon Receptor 2 antibody
Anti-IFNAR2 antibody
Anti-IFNABR antibody
Anti-IFNARB antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance